Clinical feature	Statistical test	Significant miRs	Associated with	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;	Associated with	
TIME_FROM_SPECIMEN_DX_TO_DEATH_OR_LAST_FUP	Cox regression test	N=4	shorter survival	N=0	longer survival	N=4
DAYS_TO_DEATH_OR_LAST_FUP	Cox regression test	N=30	shorter survival	N=20	longer survival	N=10
YEARS_TO_BIRTH	Spearman correlation test	N=4	older	N=1	younger	N=3
PRIMARY_SITE_OF_DISEASE	Kruskal-Wallis test	N=30	 	 	 	 
NEOPLASM_DISEASESTAGE	Kruskal-Wallis test	N=0	 	 	 	 
PATHOLOGY_T_STAGE	Spearman correlation test	N=28	higher stage	N=19	lower stage	N=9
PATHOLOGY_N_STAGE	Spearman correlation test	N=14	higher stage	N=12	lower stage	N=2
PATHOLOGY_M_STAGE	Wilcoxon test	N=0	 	 	 	 
MELANOMA_ULCERATION	Wilcoxon test	N=14	yes	N=14	no	N=0
MELANOMA_PRIMARY_KNOWN	Wilcoxon test	N=0	 	 	 	 
BRESLOW_THICKNESS	Spearman correlation test	N=30	higher breslow_thickness	N=23	lower breslow_thickness	N=7
GENDER	Wilcoxon test	N=14	male	N=14	female	N=0
RACE	Kruskal-Wallis test	N=0	 	 	 	 
ETHNICITY	Wilcoxon test	N=0	 	 	 	 
